BRPI0410055A - antagonistas de receptor de glutamato como neuroprotetores - Google Patents
antagonistas de receptor de glutamato como neuroprotetoresInfo
- Publication number
- BRPI0410055A BRPI0410055A BRPI0410055-7A BRPI0410055A BRPI0410055A BR PI0410055 A BRPI0410055 A BR PI0410055A BR PI0410055 A BRPI0410055 A BR PI0410055A BR PI0410055 A BRPI0410055 A BR PI0410055A
- Authority
- BR
- Brazil
- Prior art keywords
- glutamate receptor
- neuroprotectors
- receptor antagonists
- glutamate
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
"ANTAGONISTAS DE RECEPTOR DE GLUTAMATO COMO NEUROPROTETORES". A invenção refere-se ao uso de um inibidor de ativação mediada por t-PA do receptor de glutamato, preferivelmente do tipo NMDA, como neuroprotetor.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10337098 | 2003-05-05 | ||
DE10320336 | 2003-05-06 | ||
DE10352333 | 2003-11-06 | ||
PCT/EP2004/004776 WO2004098635A1 (de) | 2003-05-05 | 2004-05-05 | Glutamat-rezeptor-antagonisten als neuroprotektiva |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0410055A true BRPI0410055A (pt) | 2006-04-25 |
Family
ID=33436868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0410055-7A BRPI0410055A (pt) | 2003-05-05 | 2004-05-05 | antagonistas de receptor de glutamato como neuroprotetores |
Country Status (12)
Country | Link |
---|---|
US (1) | US20080213244A1 (pt) |
EP (1) | EP1622640A1 (pt) |
JP (1) | JP2006525277A (pt) |
KR (1) | KR20060015721A (pt) |
AU (1) | AU2004237407A1 (pt) |
BR (1) | BRPI0410055A (pt) |
CA (1) | CA2524342A1 (pt) |
EA (1) | EA200501753A1 (pt) |
HR (1) | HRP20050898A2 (pt) |
MX (1) | MXPA05011762A (pt) |
NO (1) | NO20055725L (pt) |
WO (1) | WO2004098635A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10153601A1 (de) | 2001-11-02 | 2003-05-22 | Paion Gmbh | DSPA zur Behandlung von Schlaganfall |
US20080057050A1 (en) * | 2003-05-02 | 2008-03-06 | Paion Deutschland Gmbh | Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke |
CA2612262A1 (en) * | 2005-06-24 | 2006-12-28 | Wilex Ag | Use of urokinase inhibitors for the treatment and/or prevention of neuropathological diseases |
AR068914A1 (es) * | 2007-10-18 | 2009-12-16 | Paion Deutschland Gmbh | Uso de un activador de plasminogeno para la preparacion de un medicamento para el tratamiento de apoplejia |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5786187A (en) * | 1995-09-21 | 1998-07-28 | The Research Foundation Of State University Of New York | Method for reducing neuronal degeneration associated with seizure |
DE10153601A1 (de) * | 2001-11-02 | 2003-05-22 | Paion Gmbh | DSPA zur Behandlung von Schlaganfall |
-
2004
- 2004-05-05 CA CA002524342A patent/CA2524342A1/en not_active Abandoned
- 2004-05-05 US US10/555,583 patent/US20080213244A1/en not_active Abandoned
- 2004-05-05 WO PCT/EP2004/004776 patent/WO2004098635A1/de active Application Filing
- 2004-05-05 KR KR1020057021076A patent/KR20060015721A/ko not_active Application Discontinuation
- 2004-05-05 EA EA200501753A patent/EA200501753A1/ru unknown
- 2004-05-05 MX MXPA05011762A patent/MXPA05011762A/es not_active Application Discontinuation
- 2004-05-05 JP JP2006505376A patent/JP2006525277A/ja active Pending
- 2004-05-05 BR BRPI0410055-7A patent/BRPI0410055A/pt not_active IP Right Cessation
- 2004-05-05 AU AU2004237407A patent/AU2004237407A1/en not_active Abandoned
- 2004-05-05 EP EP04731137A patent/EP1622640A1/de not_active Withdrawn
-
2005
- 2005-10-14 HR HR20050898A patent/HRP20050898A2/xx not_active Application Discontinuation
- 2005-12-02 NO NO20055725A patent/NO20055725L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20060015721A (ko) | 2006-02-20 |
MXPA05011762A (es) | 2006-03-30 |
AU2004237407A1 (en) | 2004-11-18 |
HRP20050898A2 (en) | 2007-03-31 |
US20080213244A1 (en) | 2008-09-04 |
WO2004098635A1 (de) | 2004-11-18 |
JP2006525277A (ja) | 2006-11-09 |
CA2524342A1 (en) | 2004-11-18 |
NO20055725D0 (no) | 2005-12-02 |
EA200501753A1 (ru) | 2006-04-28 |
NO20055725L (no) | 2005-12-02 |
EP1622640A1 (de) | 2006-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1337518T3 (da) | Piperazinylpyrazinforbindelser som antagonister for serotonin-5-HT2-receptoren | |
BR0209242A (pt) | Aminopolidiorganossiloxanos amido-funcionais | |
TNSN07196A1 (en) | Potentiators of glutamate receptors | |
GB0115862D0 (en) | Compounds | |
CR7728A (es) | Nuevas quinazolinas espirocondensadas y su uso como inhibidores de la fosfodiesterasa | |
TW200612945A (en) | Aerosol suspension formulations containing TG 227 ea as propellant | |
SMP200600024B (it) | 2,6-Biseteroaril-4-amminopirimidine come antagonisti del recettore dell'adenosina | |
UA87862C2 (en) | 4-benzylidene-piperidin derivatives | |
HRP20070374T3 (en) | Formulations comprising ecteinascidin and a disaccharide | |
DK1444215T3 (da) | 1,2,4-Thiadiazoliumderivater som melanocortinreceptormodulatorer | |
ATE461932T1 (de) | Pyrazoloä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine als antagonisten des adenosin-a2a-rezeptors | |
EP1962838A4 (en) | Farnesoid X RECEPTOR AGONISTS | |
CY1110828T1 (el) | Τροποποιημενοι πυριμιδινικοι ρυθμιστες του γλυκοκορτικοειδους υποδοχεα | |
TW200800967A (en) | Benzimidazole thiophene compounds | |
BR0206595A (pt) | Composto, composição farmacêutica, e uso de um composto | |
BRPI0112375B8 (pt) | aplidinas como derivados antitumorais | |
DE602004014772D1 (de) | Pyrrol-2,5-dithionderivate als modulatoren des liver-x-rezeptors | |
TW200517103A (en) | Peptides and compounds that bind to a receptor | |
HK1077827A1 (en) | Diazabicyclononane and-decane derivatives their use as opioid receptor ligands | |
MX2008000874A (es) | Metodos y composiciones para anticoncepcion de emergencia utilizando antagonistas del receptor de endotelina. | |
BRPI0410055A (pt) | antagonistas de receptor de glutamato como neuroprotetores | |
GB0401634D0 (en) | A surfactant | |
MXPA05012279A (es) | Derivados de bencil sulfonamida. | |
AU2003266093A1 (en) | Cyclooct-(en-)yl derivatives for use as fragrances | |
ATE275551T1 (de) | Halogenpyrimidine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |